| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $509.7M | +5.2% |
| Cost of Revenue | $321.8M | +8.3% |
| Gross Profit | $187.9M | +0.4% |
| R&D Expense | $30.3M | +38.6% |
| SG&A Expense | $243.4M | +9.9% |
| Operating Income | -$157.6M | -32.7% |
| Interest Expense | $1.5M | -70.4% |
| Pre-tax Income | -$159.3M | -957.0% |
| Income Tax | -$15.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $263.2M | -16.9% |
| Accounts Receivable | $119.7M | +6.8% |
| Inventory | $24.3M | +3.8% |
| Current Assets | $605.3M | -11.2% |
| Total Assets | $1.74B | -6.9% |
| Current Liabilities | $89.9M | +3.1% |
| Long-term Debt | $535.3M | +0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.0M | -147.0% |
| Capital Expenditures | $30.9M | -51.8% |
| Investing Cash Flow | $517K | +100.1% |
| Financing Cash Flow | $11.8M | -98.4% |
| Free Cash Flow | -$96.9M | -6.6% |
| -124.3% |
| Net Income | -$144.3M | -1628.2% |
| Total Liabilities |
| $742.0M |
| -2.6% |
| Stockholders' Equity | $998.0M | -9.9% |